SUNNYVALE, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC) today announced revenues and earnings for the quarter and year ended December 31, 2006. Revenues...
- New MDS business unit offers broader array of customer solutions by combining leadership positions in Mass Spectrometry and Cellular Analysis SUNNYVALE, Calif. and TORONTO, Jan. 29...
SUNNYVALE, Calif., Jan. 26 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC), a leader in innovative solutions for drug discovery and life sciences research, today announced...
SUNNYVALE, Calif., Jan. 17 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC), a leader in innovative solutions for drug discovery and life sciences research, today announced...
SUNNYVALE, Calif., Jan. 10 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC), a leader in innovative solutions for drug discovery and life sciences research, today announced...
SUNNYVALE, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC) today announced revenues and earnings for the quarter ended September 30, 2006. Revenues for the...
SUNNYVALE, Calif., Oct. 19 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC) will announce its third quarter 2006 earnings on Thursday, October 26, 2006 after the close of...
SUNNYVALE, Calif., Sept. 27 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC) today updated guidance for the third quarter of 2006. As a result of softer than expected...
HAYWARD, Calif., Sept. 26 /PRNewswire/ -- Multispan Inc., a technology platform company specializing in G-Protein-Coupled Receptor (GPCR) research, today announced the launch of a series of...
SUNNYVALE, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC), a leader in innovative solutions for drug discovery and life sciences research, today announced...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관